Top MarketRank™ StocksTop MarketRank™NYSE:MET MetLife (MET) Stock Price, News & Analysis $99.98 +1.16 (+1.18%) Closing price 10/26/2026 03:59 PM EasternExtended Trading$99.49 -0.49 (-0.49%) As of 07:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MetLife Stock (NYSE:MET) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MetLife alerts:Sign Up Key Stats Today's Range$99.40▼$100.8250-Day Range$93.55▼$103.6152-Week Range$67.33▼$103.65Volume3.07 million shsAverage Volume3.25 million shsMarket Capitalization$64.33 billionP/E Ratio19.15Dividend Yield2.37%Price Target$105.44Consensus RatingModerate Buy Company Overview MetLife, Inc. (NYSE: MET) is a global financial services company that provides insurance, retirement, and employee benefits solutions to individuals, employers, and institutions. Its offerings include life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products, and related financial services. Through its institutional and workplace businesses, MetLife helps employers provide benefits and retirement programs to their employees. The company also serves individual customers with protection and income products. MetLife operates primarily in the United States and has a presence in markets across Latin America, Asia, Europe, and the Middle East. Founded in 1868, MetLife has evolved from a life insurance provider into a diversified global insurer and employee benefits company. Michel A. Khalaf serves as president and chief executive officer.AI Generated. May Contain Errors. Read More MetLife Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks97th Percentile Overall ScoreMET MarketRank™: 4.84119782214 of 5 starsMetLife scored higher than 97% of companies evaluated by MarketBeat, and ranked 22nd out of 848 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingMetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.87, and is based on no strong buy ratings, 13 buy ratings, 2 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for MetLife is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageMetLife has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MetLife's stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth7.85% Earnings GrowthEarnings for MetLife are expected to grow by 7.85% in the coming year, from $9.94 to $10.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MetLife is 19.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.13.Price to Earnings Ratio vs. SectorThe P/E ratio of MetLife is 19.15, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.80.Price to Earnings Growth RatioMetLife has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioMetLife has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about MetLife's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.68% of the float of MetLife has been sold short.Short Interest Ratio / Days to CoverMetLife has a short interest ratio ("days to cover") of 3.28, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MetLife has recently decreased by 3.95%, indicating that investor sentiment is improving. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldMetLife pays a meaningful dividend of 2.40%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMetLife has been increasing its dividend for 12 years.Dividend CoverageThe dividend payout ratio of MetLife is 45.40%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, MetLife will have a dividend payout ratio of 22.11% next year. This indicates that MetLife will be able to sustain or increase its dividend.Read more about MetLife's dividend. News and Social Media3.5 / 5News Sentiment0.66 News SentimentMetLife has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.News Coverage This WeekMarketBeat has tracked 18 news articles for MetLife this week, compared to 8 articles on an average week.Search Interest10 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.MarketBeat Follows18 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MetLife insiders have not sold or bought any company stock.Percentage Held by Insiders0.40% of the stock of MetLife is held by insiders.Percentage Held by Institutions94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MetLife's insider trading history. Receive MET Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MET Stock News HeadlinesWhat You Need to Know Ahead of MetLife’s Earnings ReleaseOctober 24 at 9:11 AM | barchart.comPNB MetLife Launches Momentum Quality Index Fund for Long-Term Financial GoalsOctober 23, 2026 | finance.yahoo.com80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports to the U.S. With a January 1, 2027 deadline approaching, the Pentagon selected four companies to build critical mineral processing facilities on U.S. military bases. Only one was chosen for heavy rare earths - a Nasdaq-listed firm with an Ohio metallurgy facility under Pentagon contracts and rights to 80% of output from a major Canadian processing plant.October 27 at 1:00 AM | The Tomorrow Investor (Ad)MetLife Drops 4.2% and Loses the $100 Level in One SessionOctober 23, 2026 | 247wallst.comMetLife Inc. stock underperforms Friday when compared to competitorsOctober 23, 2026 | msn.comMetLife Slides 4.7% as Investors Weigh Mixed Signals Ahead of EarningsOctober 23, 2026 | quiverquant.comQMetLife, Inc. - preferred stock price target decreased by 12.72% to $21.32October 23, 2026 | msn.comTD Cowen Forecasts Strong Price Appreciation for MetLife (NYSE:MET) StockOctober 23, 2026 | americanbankingnews.comSee More Headlines MET Stock Analysis - Frequently Asked Questions How have MET shares performed this year? MetLife's stock was trading at $78.98 at the beginning of the year. Since then, MET stock has increased by 26.6% and is now trading at $99.9820. How were MetLife's earnings last quarter? MetLife, Inc. (NYSE:MET) released its quarterly earnings data on Wednesday, August, 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife's quarterly revenue was up 10.5% compared to the same quarter last year. Read the conference call transcript. Is MetLife doing a stock buyback? MetLife's Board of Directors approved a share buyback plan on Wednesday, August 5th 2026, which permits the company to buy back $3 billion in outstanding shares, according to EventVestor. This means that the company could repurchase up to 4.9% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its shares are undervalued. Does MetLife have any subsidiaries? The following companies are subsidiaries of MetLife: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others. Who are MetLife's major shareholders? Top institutional shareholders of MetLife include TD Waterhouse Canada Inc. (0.06%), Valley Wealth Managers Inc. (0.05%), Sterling Capital Management LLC (0.05%) and Robeco Institutional Asset Management B.V. (0.03%). Insiders that own company stock include Ramy Tadros and Bill Pappas. View institutional ownership trends. How do I buy shares of MetLife? Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MetLife own? Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include AT&T (T), Verizon Communications (VZ), Pfizer (PFE), ExxonMobil (XOM), Bank of America (BAC), GE Aerospace (GE) and Johnson & Johnson (JNJ). Company Calendar Record date for 9/8 Dividend8/04/2026Ex-Dividend for 9/8 Dividend8/04/2026Last Earnings8/05/2026Dividend Payable9/08/2026Today10/27/2026Record date for 12/8 Dividend11/03/2026Ex-Dividend for 12/8 Dividend11/03/2026Next Earnings (Estimated)11/04/2026Dividend Payable12/08/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 MET's financial health is in the Green zone, according to TradeSmith. MET has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Insurance Sub-IndustryLife & Health Insurance Current SymbolNYSE:MET CIK1099219 Webwww.metlife.com Phone(212) 578-9500Fax212-578-3320Employees46,000Year Founded1868Price Target and Rating Average Price Target for MetLife$105.44 High Price Target$115.00 Low Price Target$80.00 Potential Upside/Downside+5.5%Consensus RatingModerate Buy Rating Score (0-4)2.87 Research Coverage15 Analysts Profitability EPS (Trailing Twelve Months)$5.22 Trailing P/E Ratio19.15 Forward P/E Ratio10.06 P/E Growth0.93Net Income$3.38 billion Net Margins4.57% Pretax Margin6.13% Return on Equity23.39% Return on Assets0.89% Debt Debt-to-Equity Ratio0.52 Current Ratio0.20 Quick Ratio0.20 Sales & Book Value Annual Sales$77.08 billion Price / Sales0.83 Cash Flow$7.84 per share Price / Cash Flow12.75 Book Value$43.53 per share Price / Book2.30Miscellaneous Outstanding Shares643,440,000Free Float640,863,000Market Cap$64.33 billion OptionableOptionable Beta0.78 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:MET) was last updated on 10/26/2026 by MarketBeat.com Staff. From Our Partners80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MetLife, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MetLife With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
